95 completed, 2 withdrawn, 1 active not recruiting, 1 terminated. 67 Phase 1, 29 Phase 3, 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 67 | Completed 65, Active not recruiting 1, Withdrawn 1 |
| Phase 3 | 29 | Completed 28, Withdrawn 1 |
| Phase 4 | 2 | Completed 1, Terminated 1 |
| Not applicable | 1 | Completed 1 |
Follow Actavis Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma Manufactured Anti-BCMA CAR-T cells, Fludarabine, Cyclophosphamide - Refractory Multiple Myeloma, Relapsed Multiple Myeloma | Phase 1 | Active not recruiting | Thomas Martin, MD | 5 | 2021-10-18 | 2026-02-20 |
| A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream" Oxymetazoline Hydrochloride, Rhofade Cream, 1%, Placebo - Rosacea | Phase 3 | Completed | Actavis Inc. | 1105 | 2019-04-15 | 2021-06-23 |
| Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to Flovent® HFA 110 mcg Fluticasone propionate pressurized metered dose inhaler, Flovent HFA pressurized metered dose inhaler, Placebo pressurized metered dose inhaler - Asthma | Phase 3 | Completed | Actavis Inc. | 1902 | 2019-03-25 | 2021-09-01 |
| Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma Fluticasone Propionate and Salmeterol Inhalation Powder, Placebo Inhalation Powder - Asthma | Phase 3 | Completed | Actavis Inc. | 999 | 2018-12-03 | 2021-09-24 |
| Clinical Endpoint Study of Nepafenac 0.3% Opthalmic Suspension Nepafenac 0.3% Oph Susp, Placebos, Nepafenac 0.3% Oph Susp (reference) - Cataract | Phase 3 | Completed | Actavis Inc. | 448 | 2018-03-28 | 2021-02-16 |
| Clinical Endpoint Study of Ivermectin 0.5% Lotion Generic Ivermectin Lotion 0.5%, Sklice® (Ivermectin) Lotion 0.5%, Vehicle Lotion - Head Lice | Phase 3 | Completed | Actavis Inc. | 905 | 2017-10-07 | 2019-12-20 |
| Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants Generic Budesonide/Formoterol Fumarate Dihydrate, Symbicort® (Budesonide/Formoterol Fumarate Dihydrate), Placebo - Asthma | Phase 3 | Completed | Actavis Inc. | 1714 | 2017-01-13 | 2019-11-29 |
| An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis Ingenol Mebutate (Picato®), Generic Ingenol Mebutate, Vehicle Foam - ACTINIC KERATOSIS | Phase 3 | Completed | Actavis Inc. | 507 | 2016-08-19 | 2020-01-14 |
| A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea Generic Azelaic Acid Foam, Finacea® (Azelaic Acid) Foam, Vehicle Foam - Rosacea | Phase 3 | Completed | Actavis Inc. | 924 | 2016-07-19 | 2019-07-31 |
| Clinical Endpoint Study of Ivermectin 1% Cream Ivermectin Cream, 1%, Placebo/Vehicle cream - Moderate to Severe Papulopustular Rosacea | Phase 3 | Completed | Actavis Inc. | 630 | 2016-06-01 | 2020-06-02 |
| Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis Generic Estradiol Vaginal Cream USP, 0.01%, Estrace® Vaginal Cream USP, 0.01%, Vehicle Vaginal Cream - Atrophic Vaginitis | Phase 3 | Completed | Actavis Inc. | 663 | 2016-05-18 | 2019-12-26 |
| Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's Diarrhea Rifaximin, Xifaxan®, Placebo Tablet - Diarrhea | Phase 3 | Completed | Actavis Inc. | 739 | 2016-01-06 | 2019-12-05 |
| Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris Epiduo® Forte Gel, Adapalene and Benzoyl Peroxide Gel, placebo gel - Acne | Phase 3 | Completed | Actavis Inc. | 1001 | 2015-11-01 | 2020-06-23 |
| Randomized, Placebo-controlled Study Comparing Efficacy of Fluticasone/Salmeterol Combination to Advair in Asthmatics Fluticasone propionate 100 mcg / salmeterol 50 mcg, Generic fluticasone propionate 100 mcg / salmeterol 50 mcg, Placebo - Asthma | Phase 3 | Withdrawn | Actavis Inc. | 2015-09-01 | 2019-07-05 | |
| A Study of Hyaluronate Injectable Viscosupplement for Treatment of Osteoarthritis of the Knee Hyaluronate Injectable Viscosupplement, Euflexxa IA injection, Placebo - Osteoarthritis | Not applicable | Completed | Actavis Inc. | 599 | 2015-08-15 | 2020-06-23 |
| Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris Onexton, Clindamycin/benzoyl peroxide gel, Placebo - Acne Vulgaris | Phase 3 | Completed | Actavis Inc. | 862 | 2015-05-01 | 2020-05-27 |
| Pancreatic Enzyme Supplementation for Celiac Disease pancrelipase - Celiac Disease | Phase 4 | Terminated | Beth Israel Deaconess Medical Center | 21 | 2015-05-01 | 2021-05-12 |
| Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes Test-Brinzolamide 1% Ophthalmic suspension, Reference-Brinzolamide 1% Ophthalmic suspension - Glaucoma | Phase 3 | Completed | Actavis Inc. | 973 | 2015-04-01 | 2020-03-02 |
| Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis Generic Fluorouracil Cream, Carac® (Fluorouracil) Cream, Vehicle Cream - Actinic Keratosis | Phase 3 | Completed | Actavis Inc. | 422 | 2015-02-27 | 2019-07-17 |
| A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis Ingenol Mebutate (Picato®), Generic Ingenol Mebutate, Vehicle Foam - Actinic Keratosis | Phase 3 | Completed | Actavis Inc. | 441 | 2015-02-01 | 2020-05-12 |
Showing 20 of 99. Sign in to see all of them.
Keratosis, Actinic (6) · Asthma (4) · Rosacea (4) · Acne Vulgaris (3) · Lecithin Cholesterol Acyltransferase Deficiency (2) · Ankle Injuries (1) · Atrophic Vaginitis (1) · Breast Neoplasms (1) · Cataract (1) · Celiac Disease (1) · Dermatitis, Atopic (1) · Diarrhea (1) · Fasting (1) · Glaucoma (1) · Lymphoma, Follicular (1)
Metformin (8) · Tablets (8) · Morphine (7) · Gabapentin (6) · Bupropion (5) · Capsules (5) · Alprazolam (4) · Citalopram (3) · Glyburide (3) · Ramipril (3) · 3-ingenyl angelate (2) · Amlodipine (2) · Carvedilol (2) · Cetirizine (2) · Clobetasol (2)
United States (82) · Canada (15) · Belize (2) · Bulgaria (2) · South Africa (2) · Australia (1) · Belarus (1) · Brazil (1) · Chile (1) · Dominican Republic (1) · Germany (1) · Greece (1) · Hungary (1) · Italy (1) · Mexico (1)
James D. Carlson,, Pharm.D, (20) · Antonio R. Pizarro,, M.D. (5) · Daniel V. Freeland,, D.O., CCI (5) · Benoit Girard, M.D. (4) · Daniel V. Freeland, DO (3) · Gaetano Morelli,, MD (3) · James D. Carlson,, Pharm. D. (3) · Paul Y. Tam,, MD (3) · Christopher R. Longnecker,, M.D. (2) · Henry Lau, PhD (2) · James P. Doherty, DO (2)
PMID 18201934, PMID 29880292, PMID 30617139, PMID 31927716, PMID 36687454